Finally, we explored The Cancer Genome Atlas (TCGA) HNSCC dataset and offer evidence to support that MDSC and CTLA-4 blockade represent rational therapeutic strategies in T-cell inflamed HNSCCs. The gene discussed is CTLA4; the disease is head and neck squamous cell carcinoma.